Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.040 | 15 | 33555179 | intron variant | G/A | snv | 2.7E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.040 | 15 | 33555179 | intron variant | G/A | snv | 2.7E-02 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 15 | 33783099 | intron variant | T/C | snv | 0.16 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.040 | 15 | 33614399 | intron variant | A/G | snv | 5.5E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.040 | 15 | 33614399 | intron variant | A/G | snv | 5.5E-02 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.827 | 0.080 | 15 | 33613209 | missense variant | A/G | snv | 0.23 | 0.21 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.827 | 0.080 | 15 | 33613209 | missense variant | A/G | snv | 0.23 | 0.21 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.827 | 0.080 | 15 | 33613209 | missense variant | A/G | snv | 0.23 | 0.21 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.827 | 0.080 | 15 | 33613209 | missense variant | A/G | snv | 0.23 | 0.21 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.827 | 0.080 | 15 | 33613209 | missense variant | A/G | snv | 0.23 | 0.21 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.790 | 0.200 | 15 | 33866065 | 3 prime UTR variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.790 | 0.200 | 15 | 33866065 | 3 prime UTR variant | A/G;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.790 | 0.200 | 15 | 33866065 | 3 prime UTR variant | A/G;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.790 | 0.200 | 15 | 33866065 | 3 prime UTR variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.790 | 0.200 | 15 | 33866065 | 3 prime UTR variant | A/G;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.790 | 0.200 | 15 | 33866065 | 3 prime UTR variant | A/G;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.790 | 0.200 | 15 | 33866065 | 3 prime UTR variant | A/G;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.790 | 0.200 | 15 | 33866065 | 3 prime UTR variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.790 | 0.200 | 15 | 33866065 | 3 prime UTR variant | A/G;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.827 | 0.080 | 15 | 33613209 | missense variant | A/G | snv | 0.23 | 0.21 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.827 | 0.080 | 15 | 33613209 | missense variant | A/G | snv | 0.23 | 0.21 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.827 | 0.080 | 15 | 33613209 | missense variant | A/G | snv | 0.23 | 0.21 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.827 | 0.080 | 15 | 33613209 | missense variant | A/G | snv | 0.23 | 0.21 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
1.000 | 0.080 | 15 | 33768539 | intron variant | C/T | snv | 0.67 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 15 | 33768539 | intron variant | C/T | snv | 0.67 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 |